Search results

From Self-sufficiency
Jump to: navigation, search
  • ...r the early treatment of moderately severe malaria in children: randomised clinical trial | journal=Brit Med J | volume=332 | issue=7549 | pages=1055&ndash;57 ...nent.<ref>{{cite journal | doi=10.1038/clpt.1994.32 | author=Department of Clinical Pharmacology, Huddinge University Hospital, Sweden | title=The concentratio
    27 KB (3,844 words) - 16:41, 27 September 2010
  • ...ificant therapeutic value as an anti-malarial drug. It was introduced into clinical practice in 1947 for the prophylactic treatment of malaria.<ref>http://www. * Chloroquine is in clinical trials as an investigational [[antiretroviral]] in humans with [[AIDS|HIV-1
    16 KB (2,187 words) - 16:41, 27 September 2010
  • ==Clinical use== ...pmid = 17371789 | issue = 7}}</ref> suggest that the prior pharmacokinetic studies of N-acetylcysteine did not include [[Acetylation]] as a reason for the low
    28 KB (3,682 words) - 16:42, 27 September 2010
  • <!--Clinical data--> ...].<ref>{{cite book|last1=Roberts|first1=James R.|title=Roberts and Hedges' clinical procedures in emergency medicine|date=2014|publisher=Elsevier Health Scienc
    33 KB (4,541 words) - 10:57, 17 June 2016
  • ...he end of its patent life, and partially due to mixed results from various studies. Following almost 200 studies of 11 anti-seizure drugs, the FDA has also warned of an increased suicide r
    12 KB (1,686 words) - 16:42, 27 September 2010
  • ==Clinical use== ...[[fluorouracil]] to treat [[colon cancer]]. There is no good evidence from clinical trials that its addition to fluorouracil therapy benefits patients with col
    10 KB (1,350 words) - 16:42, 27 September 2010
  • ...antel has a particularly dramatic effect on patients with schistosomiasis. Studies of those treated have shown that within six months of receiving a dose of p ...l.<ref>{{cite journal |author=Quinn DI, Day RO |title=Drug interactions of clinical importance. An updated guide |journal=Drug Saf |volume=12 |issue=6 |pages=3
    12 KB (1,580 words) - 16:42, 27 September 2010
  • ...and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris |journal=Clin Ther |volu
    25 KB (3,261 words) - 14:17, 11 September 2010
  • <ref>[http://www.jbc.org/content/238/7/2498.full.pdf Studies on the Mechanism of Action of Chloramphenicol ] July 1963. The Journal of B ...as a single intramuscular injection. The dose is repeated if there is no clinical response after 48 hours. A single injection costs approximately [[United S
    29 KB (3,876 words) - 16:42, 27 September 2010
  • ...her JL, Hull DS, Davis LS |title=Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline |journal=Arch Dermatol |volume= ...ff A, Massung RF, Christensson B |title=Human granulocytic ehrlichiosis--a clinical case in Scandinavia |journal=Scand. J. Infect. Dis. |volume=33 |issue=1 |pa
    20 KB (2,578 words) - 16:43, 27 September 2010
  • ...irth defects. Those studies are nowadays considered flawed and more recent studies "do not support a significant increased risk for birth defects or other adv ...ment.<ref name="AMH2006" /> However, the mechanism of this reaction in the clinical setting has recently been questioned by some authors,<ref name="Williams200
    19 KB (2,528 words) - 16:43, 27 September 2010
  • ...re mutually antagonistic ''in vitro''. It is not known whether this is of clinical significance, but the combination should be avoided. ...or=Richards WA, ''et al.'' | title=Nitrofurantoin: Clinical and laboratory studies in urinary tract infections | journal=Arch Intern Med | year=1955 | volume=
    12 KB (1,576 words) - 16:43, 27 September 2010
  • ...ite journal|author=Kremers P, Duvivier J, Heusghem C|title=Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses|journal=J Clin Pha ==Clinical indications==
    10 KB (1,346 words) - 16:43, 27 September 2010
  • ==Clinical use== |title=Serum vancomycin concentrations: reappraisal of their clinical value
    31 KB (4,198 words) - 16:43, 27 September 2010
  • ...olerate the effects of [[Dapsone]] for Tuberculosis.<ref name="ReferenceA">Clinical Microbiology Made Ridiculously Simple</ref> ...researcher named Chang identified its effectiveness against leprosy. After clinical trials in Nigeria and elsewhere during the 1960s, some sponsored by the Swi
    12 KB (1,651 words) - 16:43, 27 September 2010
  • ...Organisation|WHO]] recommend its use in pregnancy; and there is extensive clinical experience to show that it is safe. In the U.S., pyrazinamide is not used | title = Clinical and molecular analysis of patients with renal hypouricemia in Japan-influen
    12 KB (1,557 words) - 16:44, 27 September 2010
  • ...|title=Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres |journal=J Drug Target ...d Richard T. liposomal formulation, structure, mechanism of action and pre-clinical experience. Journal of Antimicrobial Chemotherapy (2002) 49, 21-30</ref> Th
    13 KB (1,785 words) - 16:44, 27 September 2010
  • ...Guchelaar HJ, Dankert J |title=Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions |journal=J. A ...rains of ''[[Candida (genus)|Candida]]'' and ''[[Cryptococcus]]''. Limited studies demonstrate that flucytosine may be of value against infections with ''[[Sp
    10 KB (1,394 words) - 16:44, 27 September 2010
  • ...e analyses of plasma HIV RNA levels and CD4 cell counts in two Phase III [[clinical trial]]s of Emtriva of 48 weeks duration. ...er being evaluated as a potential treatment for chronic hepatitis B. These studies are ongoing.
    5 KB (667 words) - 16:44, 27 September 2010
  • ...s. There are no study results demonstrating the effect of tenofovir on the clinical progression of HIV. | title = Additional Studies Needed to Assess Effectiveness of Tenofovir for Prevention
    6 KB (871 words) - 16:45, 27 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)